A prospective study of travellers' diarrhoea : analysis of pathogen findings by destination in various (sub)tropical regions by Lääveri, Tinja et al.
lable at ScienceDirect
Clinical Microbiology and Infection 24 (2018) 908.e9e908.e16Contents lists avaiClinical Microbiology and Infection
journal homepage: www.cl in icalmicrobiologyandinfect ion.comOriginal articleA prospective study of travellers' diarrhoea: analysis of pathogen
findings by destination in various (sub)tropical regions
T. L€a€averi 1, K. Vilkman 1, 2, S.H. Pakkanen 3, J. Kirveskari 4, A. Kantele 1, 2, 5, 6, *
1) Inflammation Center, Division of Infectious Diseases, Helsinki University Hospital, Finland and University of Helsinki, Finland
2) Aava Travel Clinic, Medical Centre Aava, Helsinki, Finland
3) Department of Bacteriology and Immunology, University of Helsinki, Finland
4) Department of Bacteriology, Helsinki University Hospital Laboratory (HUSLAB), Finland
5) Clinicum, University of Helsinki, Finland
6) Unit of Infectious Diseases, Department of Medicine/Solna, Karolinska Institutet, Stockholm, Swedena r t i c l e i n f o
Article history:
Received 19 June 2017
Received in revised form
12 September 2017
Accepted 24 October 2017












Travellers' diarrhoea* Corresponding author. A. Kantele, Inflammation
Diseases, Helsinki University Hospital, POB 348, FIN-0
E-mail address: anu.kantele@hus.fi (A. Kantele).
https://doi.org/10.1016/j.cmi.2017.10.034
1198-743X/© 2017 The Authors. Published by Elsevier
the CC BY-NC-ND license (http://creativecommons.ora b s t r a c t
Objectives: Eighty million travellers visiting (sub)tropical regions contract travellers' diarrhoea (TD) each
year, yet prospective data comparing the prevalence of TD pathogens in various geographical regions are
scarce. Our recent study using modern molecular methods found enteropathogenic (EPEC) and enter-
oaggregative (EAEC) Escherichia coli to be the most frequent pathogens, followed by enterotoxigenic
E. coli (ETEC) and Campylobacter. We revisited our data to compare the findings by geographical region.
Methods: A total of 459 prospectively recruited travellers provided stool samples and completed ques-
tionnaires before and after visiting destinations in various geographical regions. A multiplex quantitative
real-time PCR assay was used to analyse Salmonella, Yersinia, Campylobacter jejuni/Campylobacter coli,
Shigella, Vibrio cholerae, EPEC, EAEC, ETEC, enterohaemorrhagic E. coli and enteroinvasive E. coli.
Results: TD was contracted by 69% (316/459) of the subjects; EPEC and EAEC outnumbered ETEC and
Campylobacter in all regions. Multiple pathogens were detected in 42% (133/316) of the samples. The
proportions of all pathogens varied by region. The greatest differences were seen for Campylobacter:
while relatively frequent in South Asia (n ¼ 11; 20% of the 55 with TD during travel) and Southeast Asia
(15/84, 15%), it was less common in East and West Africa (5/71, 7% and 1/57, 2%) and absent in South
America and the Caribbean (0/40).
Conclusions: EPEC and EAEC outnumbered ETEC and Campylobacter everywhere, yet the proportions of
pathogen findings varied by region, with ETEC and Campylobacter rates showing the greatest differences.
The high frequency of multibacterial findings in many regions indicates a need for further investigation
of the clinical role of each pathogen. T. L€a€averi, Clin Microbiol Infect 2018;24:908.e9e908.e16
© 2017 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction few data are available comparing the incidence of the variousTravellers' diarrhoea (TD) accounts for more than 80 million
cases each year [1]. It is not only the disease most commonly
encountered by travellers to (sub)tropical destinations [2,3] but
also themost common health complaint at posttravel consultations
[2,4]. Bacterial pathogens are known to predominate as aetiologic
agents. However, the pathogen remains unidentified in up to half of
cases [5,6]. Over the past decade the field of TD research has
experienced a renaissance, with newmolecular methods covering a
larger variety of pathogens than traditional approaches. However,Center, Division of Infectious
0029 HUS, Finland.
Ltd on behalf of European Society
g/licenses/by-nc-nd/4.0/).pathogens by geographical area.
Until recently, enterotoxigenic Escherichia coli (ETEC) has been re-
ported to outnumber all other pathogens causing TD in most regions
[5,6], with the exception of Southeast Asia (Thailand), where
Campylobacter has been considered the primary pathogen [5e9].
Studies using modern molecular methods have decreased the pro-
portion of unexplained TD cases to only 4% to 24% [10e12]. These in-
vestigations have also revealed diarrhoeagenic E. coli (DEC) to be even
more prevalent than previously thought. The rates for enteropatho-
genic E. coli (EPEC) and enteroaggregative E. coli (EAEC) have been at
least as high as those for ETEC even after visiting Central America
[11,13], South Asia [10] or Africa [10,12,14], where earlier findings have
beenpredominatedbyETEC.Otherbacterial pathogens suchas Shigella,of Clinical Microbiology and Infectious Diseases. This is an open access article under
T. L€a€averi et al. / Clinical Microbiology and Infection 24 (2018) 908.e9e908.e16 908.e10Salmonella spp., enteroinvasive and enterohaemorrhagic E. coli (EIEC
and EHEC respectively), Aeromonas spp., Plesiomonas shigelloides,
Arcobacter spp., enterotoxigenic Bacteroides fragilis and Vibrio spp. have
been detected less frequently [5,6].
We found only a handful of reports providing data on TD
pathogens by region in a single study using modern molecular
methods. EPEC has only been covered in a few investigations.
Moreover, EAEC prevalence data among travellers to Southeast Asia
and East Africa remain virtually nonexistent.
In our prospective study of 459 Finnish travellers, we applied
multiplex quantitative real-time PCR (qPCR) methodology to
analysis of various TD pathogens by region, seeking to challenge the
current understanding of regionally predominant pathogens.
Materials and methods
Study population and recruitment
The participants for this prospective study were initially enrolled
at the Travel Clinic of Aava Medical Centre, Helsinki, Finland, over a
12-month period in 2009e2010 before their journey outside the
Nordic countries for more than four nights. Of the 526 volunteers,
459 (63%) completed questionnaires and provided stool samples
before and after travel (Supplementary Fig. S1). Ethical approval was
obtained from the ethics committee of the department of medicine
at Helsinki University Hospital. All study subjects provided written
informed consent. We earlier reported the findings of resistant
Enterobacteriaceae [15] and travel-related health problems [3] in the
same volunteers. Recently we described the stool pathogens of 382
travellers who did not use antimicrobials [16].
Definition of TD
TD was defined according to World Health Organization criteria
as passage of loose or liquid stools more frequently than is normal
for the individual (http://www.who.int/topics/diarrhoea/en/). Se-
vere TD was defined as six or more diarrhoeal stools per day, TD
accompanied by fever or haemorrhagic stools, or TD requiring
hospitalization.
Questionnaires
The pretravel questionnaire included demographic data and
information on possible diarrhoeal symptoms at the time of the
first faecal sample. The posttravel questionnaire assessed the travel
itinerary, diarrhoeal and other symptoms, and medications during
or immediately after travel.
Travel destinations
The countries visited were grouped into regions as modified
from the United Nations classification: South Asia; Southeast Asia;
East Asia; North Africa and Middle East; East Africa; West Africa
(Western andMiddle Africa); Southern Africa; Latin America (South
and Central America and the Caribbean); and Europe, Australia and
North America. The 37 travellers (8%) who visited more than one
region were grouped by longest stay; 16 (43%) of these visited
Europe or the United States on their way to the (sub)tropics. This
report focuses on the five most popular destinations: South Asia,
Southeast Asia, East Africa, West Africa and Latin America.
Collection and laboratory analysis of stool samples
Briefly, stool samples were collected before departure and from
the first (or second) stool passed after returning home as swabs inCopan M40 Transystem tubes (Copan Diagnostics, Brescia, Italy)
and mailed in special boxes, reaching the laboratory within 1 to
3 days. Once the samples arrived, total nucleic acids were extracted
using the standard semiautomated protocol of easyMAG (bio-
Merieux, Marcy l’Etoile, France). The analyses were carried out with
a multiplex qPCR method [1] which covers the following patho-
gens: Campylobacter jejuni and Campylobacter coli, Salmonella spp.,
Yersinia, Vibrio cholerae, EPEC, EAEC, ETEC, EHEC and EIEC/Shigella
spp. Here we focus on the findings of pathogens found to associate
with ongoing TD symptoms discussed in our previous report (EPEC,
EAEC, ETEC and Campylobacter) [16].
Statistical analysis
Statistical analyses were carried out by SPSS 22 (IBM SPSS,
Chicago, IL, USA).
The chi-square test or binary logistic regression analysis was
used to compare categorical variables when applicable. A binomi-
nal regression model was used to obtain profile likelihood confi-
dence intervals (CIs) for the proportions of different pathogens in
geographical regions; in cases when computation did not converge,
asymptotic Wald CIs were used. Statistical significance was deter-
mined as either 95% CIs not overlapping, or ranging only either
above or below 1.
Results
Demographic data and occurrence of TD
Background data on the travellers and their travels are shown in
Supplementary Table S1. TDwas reported by 316 travellers (69%). At
the time of the posttravel stool sample, 143 (31%) reported having
ongoing symptoms, 173 (38%) reported that symptoms had already
resolved and 143 (31%) were asymptomatic through the entire
journey. Seventy-two (16%) reported having taken antimicrobial
medications during travel. TDwasmost common among thosewho
visited South Asia (55/69, 80%), Southeast Asia (84/108, 79%) and
East Africa (71/96, 74%), while 67% (57/85) of those who travelled to
West Africa and 60% (24/40) to Latin America reported TD
(Supplementary Table S2). There were no significant differences
between regions in the severity of TD (severe vs. nonsevere TD, p
0.118; data not shown).
Pathogen findings in stool samples of all 459 travellers
Nineteen (4%) of 459 pretravel samples were positive for bac-
terial pathogens; only one subject with EPEC reported mild diar-
rhoeal symptoms. An analysis of the posttravel stool samples of all
459 subjects (Table 1) revealed EPEC (n¼ 194; 42%) and EAEC (192;
42%) to be the most common pathogens, outnumbering both ETEC
(88; 19%) and Campylobacter (31; 7%). EHEC was identified in 37
(8%), Salmonella in 11 (2%) and EIEC/Shigella in six (1%) stool sam-
ples. Vibrio cholerae and Yersinia were not detected. Two or more
types of bacterial pathogens were found in 168 (37%) of all post-
travel faecal samples; 57 (12%) had three or more pathogens.
EPEC, EAEC, ETEC and Campylobacter findings in stool samples of
travellers to five regions
The findings of EPEC, EAEC, ETEC and Campylobacter in relation
to symptoms among travellers to South Asia, Southeast Asia, East
Africa, West Africa and Latin America are presented in
Supplementary Table S2 and in Figs. 1e3. Pathogen findings from
countries with more than ten visitors are presented in
Supplementary Table S3.
Table 1







EPEC EAEC ETEC EHEC Only DEC Only non-DEC Campylobacter Salmonella Shigella/EIEC
Total (% of all) 459 326 (71) 168 (37) 193 (42) 192 (42) 88 (19) 37 (8) 223 (49) 12 (3) 31 (7) 11 (2) 6 (1)
Proportion of travellers with TD by pathogen finding
TD during
travel
316 (69) 241 (74) 133 (79) 134 (69) 152 (79) 76 (86) 27 (73) 159 (71)a 11 (92)a 30 (97) 8 (73) 5 (83)
OR (95% CI) TD
during travel
vs. no TDa
2.2 (1.4e3.3) 2.2 (1.4e3.5) 1.0 (0.7e1.6) 2.4 (1.6e3.7) 3.5 (1.8e6.6) 1.2 (0.6e2.6) 1.6 (1.0e2.4) 8.5 (1.1e67.8) 14.9 (2.0e110.3) 1.2 (0.3e4.6) 2.3 (0.3e19.7)
Findings by geographical region
Asia (all) 184 (40) 130 (71) 69 (38) 83 (45) 74 (40) 35 (19) 10 (5) 78 (42) 12 (7) 25 (14) 7 (4) 2 (1)
South Asia 69 (15) 54 (78) 37 (54) 37 (54) 39 (57) 15 (22) 7 (10) 29 (42) 2 (3) 12 (17) 1 (1) 2 (3)
Southeast Asia 108 (24) 74 (68) 31 (29) 44 (41) 34 (31) 20 (19) 3 (3) 48 (44) 10 (9) 13 (12) 6 (6) 0 (0)
East Asia 7 (2) 2 (29) 1 (14) 2 (29) 1 (14) 0 (0) 0 (0) 1 (14) 0 (0) 0 (0) 0 (0) 0 (0)




13 (3) 8 (62) 1 (8) 5 (39) 3 (23) 0 (0) 1 (8) 7 (54) 0 (0) 0 (0) 0 (0) 0 (0)




85 (19) 60 (71) 32 (38) 36 (42) 39 (46) 14 (16) 7 (8) 40 (47) 0 (0) 1 (1) 1 (1) 4 (5)











17 (4) 3 (18) 2 (12) 0 (0) 3 (18) 1 (6) 1 (6) 3 (18) 0 (0) 0 (0) 0 (0) 0 (0)
Data are presented as n (%) unless otherwise indicated. No Yersinia or Vibrio cholerae were detected.
CI, confidence interval; DEC, diarrhoeagenic Escherichia coli; EAEC, enteroaggregative E. coli; EHEC, enterohaemorrhagic E. coli; EIEC, enteroinvasive E. coli; EPEC, enteropathogenic E. coli; ETEC, enterotoxigenic E. coli; OR, odds
ratio; TD, travellers' diarrhoea.
















Fig. 1. Map showing proportions of findings for EPEC, EAEC, ETEC and Campylobacter, any pathogen or multiple pathogens among 459 Finnish travellers to South Asia, Southeast
Asia, East Africa, West Africa and Latin America. EAEC, enteroaggregative Escherichia coli; EHEC, enterohaemorrhagic Escherichia coli; EPEC, enteropathogenic Escherichia coli.
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Bacterial pathogens were found in 82% (45/55) of stool samples
from travellers to South Asia with TD. EAEC (33/55, 60%) and EPEC
(31/55, 56%) were more common findings than ETEC (15/55, 27%)Fig. 2. Map showing proportions of findings for EPEC, EAEC, ETEC and Campylobacter, any
oaggregative Escherichia coli; EHEC, enterohaemorrhagic Escherichia coli; EPEC, enteropathoand Campylobacter (11/55, 20%); 60% (33/55) had two ormore types
of pathogens and 31% (14/55) had three or more. Of those whose
symptoms had already resolved, Campylobacter was found in 30%
(8/27). Of asymptomatic travellers, 64% (9/14) had a pathogen
finding; 43% (6/14) had either EAEC or EPEC.pathogen or multiple pathogens among travellers with TD during travel. EAEC, enter-
genic Escherichia coli; TD, travellers' diarrhoea.
Fig. 3. Map showing proportions of findings for EPEC, EAEC, ETEC and Campylobacter, any pathogen or multiple pathogens among travellers who remained asymptomatic during
travel. EAEC, enteroaggregative Escherichia coli; EHEC, enterohaemorrhagic Escherichia coli; EPEC, enteropathogenic Escherichia coli.
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Among the 108 travellers to Southeast Asia, pathogens were
found in 75% (63/84) of those with TD. EPEC (35/84, 42%) and EAEC
(31/84, 37%) were themost frequent findings, followed by ETEC (17/
84, 20%) and Campylobacter (13/84, 15%). Among travellers with
ongoing TD, multiple pathogens were detected in 50% (12/24), EPEC
in 50% (12/24), EAEC in 38% (9/24), ETEC in 33% (8/24) and
Campylobacter in 17% (4/24). Of those remaining asymptomatic,
46% (11/24) had a pathogen finding.
TD pathogens of travellers to West Africa
Among the 85 travellers toWest Africa, pathogens were found in
72% (41/57) of those with TD. EAECwas detected in 47% (27/57) and
EPEC in 40% (23/57), followed by ETEC in 23% (13/57) and
Campylobacter in 2% (1/57). Two or more types of pathogens were
found in 44% (25/57). In asymptomatic travellers, 68% (19/28) had
pathogen findings.
TD pathogens of travellers to East Africa
Of the 96 travellers to East Africa, a pathogenwas detected in the
faecal samples of 85% (60/71) of those with TD. ETEC was almost as
common (27/71, 38%) as EPEC (41/71, 58%) and EAEC (41/71, 44%).
Campylobacter was detected in 7% (5/71). Two or more different
types of pathogens were detected in 52% (37/71). These proportions
were similar among travellers with ongoing TD. Of asymptomatic
travellers, 80% (20/25) had pathogen findings.
TD pathogens of travellers to Latin America
Among 40 travellers to Latin America, pathogens were found in
79% (19/24) of those having experienced TD. EAEC (14/24, 54%) andEPEC (7/24, 30%) were found more commonly than ETEC (3/24,
13%); 30% (7/24) had two or more types of pathogens. Campylo-
bacter was not detected. Among travellers with ongoing TD, EAEC,
EPEC and ETEC were found in equal proportions (3/10, 30%). Of
asymptomatic travellers, 75% (12/16) had pathogen findings.
Differences between regions by pathogens found in travellers with
TD during travel
Geographical comparisons by pathogen of travellers with TD are
presented in Table 2. The results with statistical significance are
provided here.
EPEC
The region with the highest proportion was South Asia (56%);
the comparison to Latin America was significant (29%, odds ratio
(OR) 0.3, 95% CI 0.1e0.9).
EAEC
This pathogen was found more frequently in samples from
travellers to South Asia than Southeast Asia (60% vs. 37%, OR 0.4,
95% CI 0.2e0.8).
ETEC
The highest proportion of this pathogen was detected among
those visiting East Africa (38%); the comparison to Southeast Asia
(20%, OR 0.4; 95% CI 0.2e0.9) and Latin America (13%, OR 0.2; 95% CI
0.1e0.9) was significant.
Campylobacter
This pathogen was most commonly detected among travellers to
South Asia (20%); the proportions were significantly lower in West
Africa (2%, OR 0.1, 95% CI 0.01e0.6) and East Africa (7%, OR 0.3, 95% CI
0.1e0.9).No caseswithCampylobacterweredetected in LatinAmerica.
Table 2
Relationship among pathogen findings and travel destination among travellers with TD during travel
Pathogen and
travel destination
All travellers TD during travel Ongoing TD Asymptomatic
n (%) of travellers
to region
p OR (95% CI) n (%) of travellers
to region
p OR (95% CI) n (%) of travellers
to region
p OR (95% CI) n (%) of travellers to region p OR (95% CI)
Any pathogen
South Asia 54 (79) 0.412 0.7 (0.3e1.6) 45 (82) 0.688 0.8 (0.3e2.1) 24 (86) 1.0 9 (64) 0.286 0.5 (0.1e2.0)
Southeast Asia 74 (69) 0.015 0.4 (0.2e0.9) 63 (75) 0.148 0.6 (0.2e1.2) 18 (75) 0.334 0.5 (0.1e2.0) 11 (46) 0.016 0.2 (0.1e0.8)
West Africa 60 (71) 0.043 0.5 (0.2e1.0) 41 (72) 0.087 0.5 (0.2e1.1) 19 (73) 0.256 0.5 (0.1e1.8) 19 (68) 0.320 0.5 (0.2e1.9)
East Africa 80 (83) 1.0 60 (85) 1.0 33 (85) 0.901 0.9 (0.2e3.6) 20 (80) 1.0
Latin America 31 (78) 0.425 0.7 (0.3e1.7) 19 (79) 0.547 0.7 (0.2e2.3) 7 (70) 0.281 0.4 (0.1e2.2) 12 (75) 0.706 0.8 (0.2e3.4)
Multiple pathogens
South Asia 37 (54) 1.0 33 (60) 1.0 18 (64) 1.0 4 (29) 0.346 0.5 (0.1e2.1)
Southeast Asia 31 (29) 0.001 0.3 (0.2e0.7) 27 (32) 0.001 0.3 (0.2e0.6) 12 (50) 0.300 0.6 (0.2e1.7) 4 (17) 0.044 0.3 (0.1e1.0)
West Africa 32 (38) 0.048 0.5 (0.3e1.0) 25 (44) 0.089 0.5 (0.2e1.1) 13 (50) 0.291 0.6 (0.2e1.7) 7 (25) 0.149 0.4 (0.1e1.4)
East Africa 48 (50) 0.646 0.9 (0.5e1.6) 37 (52) 0.141 0.7 (0.4e1.5) 18 (46) 0.145 0.5 (0.2e1.3) 11 (44) 1.0
Latin America 11 (28) 0.009 0.3 (0.1e0.8) 7 (29) 0.014 0.3 (0.1e0.8) 3 (30) 0.071 0.2 (0.1e1.1) 4 (25) 0.223 0.4 (0.1e1.7)
EPEC
South Asia 37 (54) 1.0 31 (56) 1.0 17 (61) 1.0 6 (43) 0.285 0.5 (0.1e1.9)
Southeast Asia 44 (41) 0.094 0.6 (0.3e1.1) 35 (42) 0.091 0.6 (0.3e1.1) 12 (50) 0.439 0.6 (0.2e1.9) 9 (38) 0.125 0.4 (0.1e1.3)
West Africa 36 (42) 0.165 0.6 (0.3e1.2) 23 (40) 0.091 0.5 (0.2e1.1) 14 (54) 0.610 0.8 (0.3e2.2) 13 (46) 0.307 0.5 (0.1e1.8)
East Africa 45 (47) 0.393 0.8 (0.4e1.4) 31 (44) 0.158 0.6 (0.3e1.2) 18 (46) 0.241 0.6 (0.2e1.5) 14 (56) 0.681 0.8 (0.2e2.8)
Latin America 17 (43) 0.264 0.6 (0.3e1.4) 7 (29) 0.029 0.3 (0.1e0.9) 3 (30) 0.105 0.3 (0.1e1.3) 10 (63) 1.0
EAEC
South Asia 39 (57) 1.0 33 (60) 1.0 18 (64) 1.0 6 (43) 1.0
Southeast Asia 34 (31) 0.001 0.4 (0.2e0.7) 31 (37) 0.008 0.4 (0.2e0.8) 9 (38) 0.057 0.3 (0.1e1.0) 3 (13) 0.043 0.2 (0.04e1.0)
West Africa 39 (46) 0.190 0.7 (0.3e1.2) 27 (47) 0.181 0.6 (0.3e1.3) 12 (46) 0.183 0.5 (0.2e1.4) 12 (43) 1.000 1.0 (0.3e3.7)
East Africa 50 (52) 0.573 0.8 (0.4e1.6) 41 (56) 0.799 0.9 (0.4e1.9) 19 (49) 0.208 0.5 (0.2e1.4) 9 (36) 0.673 0.8 (0.2e2.9)
Latin America 15 (38) 0.057 0.5 (0.2e1.0) 13 (54) 0.629 0.8 (0.3e2.1) 3 (30) 0.071 0.2 (0.1e1.1) 2 (13) 0.074 0.2 (0.03e1.2)
ETEC
South Asia 15 (22) 0.106 0.6 (0.3e1.1) 15 (27) 0.206 0.6 (0.3e1.3) 10 (36) 0.660 0.8 (0.3e2.2) 0 (0) NA
Southeast Asia 20 (19) 0.017 0.5 (0.2e0.9) 17 (20) 0.016 0.4 (0.2e0.8) 8 (33) 0.542 0.7 (0.2e2.1) 3 (13) 0.481 0.6 (0.1e2.7)
West Africa 14 (16) 0.011 0.4 (0.2e0.8) 13 (23) 0.067 0.5 (0.2e1.1) 7 (27) 0.247 (0.5 80.2e1.6) 1 (4) 0.092 0.1 (0.02e1.4)
East Africa 32 (33) 1.0 27 (38) 1.0 44 (35) 1.0 5 (20) 1.0
Latin America 4 (10) 0.008 0.2 (0.1e0.7) 3 (13) 0.028 0.2 (0.1e0.9) 3 (30) 0.526 0.6 (0.1e2.7) 1 (6) 0.249 0.3 (0.03e2.5)
Campylobacter
South Asia 12 (17) 1.0 11 (20) 1.0 3 (11) 0.534 0.6 (0.1e3.0) 1 (7) NA NA
Southeast Asia 13 (12) 0.321 0.7 (0.3e1.5) 13 (15) 0.491 0.7 (0.3e1.8) 4 (17) 1.0 0 (0) NA NA
West Africa 1 (1) 0.006 0.1 (0.01e0.4) 1 (2) 0.013 0.1 (0.01e0.6) 0 (0) 0.998 NA 0 (0) NA NA
East Africa 5 (5) 0.016 0.3 (0.1e0.8) 5 (7) 0.037 0.3 (0.1e0.9) 3 (8) 0.282 0.4 (0.1e2.1) 0 (0) NA NA
Latin America 0 (0) 0.998 NA 0 (0) 0.998 NA 0 (0) 0.999 NA 0 (0) NA NA
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Multiple pathogen findings were more frequent among travel-
lers to South Asia (60%) than Southeast Asia (32%; OR 0.3, 95% CI
0.2e0.6) or Latin America (29%; OR 0.3, 95% CI 0.1e0.8).
Discussion
The perception of TD aetiology has been revolutionized by
modernmolecular methods offering high sensitivity and covering a
wide range of pathogens. ETEC has long been considered the most
common TD pathogen (apart from in Thailand) [5,6]. Our earlier
data showed EPEC and EAEC to predominate [16], which is in
accord with other recent findings [10e12,14]. The regional differ-
ences revealed by our analysis were mostly related to ETEC and
Campylobacter. We next discuss our pathogen findings by region.
South Asia: multiple pathogen findings
Our data show multiple pathogens to be especially common
among travellers to South Asia. Of those with ongoing TD, 64% had
more than one pathogen in their stool samples. This corresponds
with earlier investigations reporting rates of 27% to 60% for mul-
tiple pathogens [17,18]. We also detected pathogens in the stools of
74% of the asymptomatic travellers, 29% of whom were coinfected.
Indeed, our data indicate that travellers visiting the region are very
commonly exposed to stool pathogens.
Some reports suggest that Campylobacter may be contracted in
South Asia as frequently as in Southeast Asia [18e20]. Corre-
spondingly, we found Campylobacter among 20% and 15% of trav-
ellers with TD visiting South Asia and Southeast Asia, respectively.
However, even in South Asia, EAEC (60%) and EPEC (56%) were the
most common pathogens, followed by ETEC (27%). Although
consistent with some other studies [10,17], this observation is
contradicted by Jiang et al. [18], who reported only 5% to be infected
with EAEC, but 76% with ETEC and 20% with Campylobacter. The
varying detection rates for EAECmay be explained bymethodologic
differences. In our data, DEC strains were seen in all but two stool
samples with a pathogen finding.
Southeast Asia: DEC more common than Campylobacter
Review articles looking at travellers to Southeast Asia report
Campylobacter to be the most common TD pathogen (25e35%),
with low proportions of DEC infections [5,6]. Our findings in this
geographical region contradict previous reports. We detected both
EPEC and EAEC (42% and 37% of travellers with TD, respectively)
more frequently than Campylobacter (15%); ETEC was seen in 20%.
One reason for overestimating the role of Campylobactermay be the
limited coverage of the various DEC in earlier investigations among
travellers to Southeast Asia; we are not aware of any studies
covering all four pathogensdEAEC, EPEC, ETEC and Campylo-
bacterdin a single report. Moreover, it should be noted that most
research into TD in Thailand has been conducted by studying mil-
itary personnel instead of ordinary tourists [7e9]. The high rate of
DEC (87% of our pathogen findings) in our data shows a greater
prevalence of these pathogens in Southeast Asia than previously
reported.
West Africa: DEC predominate
The few fairly recent studies of TD aetiology in Western or
Middle Africa [10,12,14] have presented results concurring with
ours showing EAEC and EPEC (47% and 40% of those with TD during
travel) to be at least as common as ETEC (23%) among travellers to
West Africa. These data dispute earlier investigations finding ETECpredominant and other DEC uncommon [21e23]. Togetherwith the
very low rates of Campylobacter (2%), our data indicate that DEC
also predominates in this geographical area.
East Africa: ETEC especially common
Interestingly, in East Africa, coinfections were almost as common
as in South Asia; DEC were identified in all stool samples with a
positive pathogen finding. We are aware of only two studies pub-
lished over the past 30 years analysing TD among travellers to East
Africa. Among 464 travellers, Jiang et al. [24] identified ETEC in the
specimensof35%visitingKenya (5%hadCampylobacter;EPECorEAEC
were not screened for), and Paschke et al. [10] reported that of 12
travellers to East Africa, six had EAEC, four had heat-labile ETEC and
four heat-stable ETEC; EPECwas not analysed. In our data, East Africa
was the regionwith the highest rate of ETEC,which correspondswith
the rates in earlier reports [10,24], yet here also EPEC and EAEC were
equally frequent. Our five Campylobacter cases (7% of those 71 with
TD) inEastAfricaandone case (1/57, 2%) inWestAfrica support earlier
observations [19] of a tenfold difference in the risk between East and
West Africa. The cause of the great regional variations in Campylo-
bacter findings among travellers has remained unclear.
Latin America: other DEC as common as ETEC
Our data accord with recent studies [11,13,17,25] indicating
considerable frequency of EAEC in Latin America [18,26], but
contradict others reporting EAEC in only 3% to 13% of TD cases
[18,26]. To our knowledge, only one study has included EPEC in the
analyses of TD pathogens in Latin America [11]; our results showing
29% of travellers with TD to have EPEC concur with these findings.
In our data, EPEC and EAEC were as commonly found as ETEC.
Consistent with earlier investigations, we found no cases of
Campylobacter [5,6,27]. It should be noted that only seven of our 40
volunteers visited Mexico or Guatemala, where the earlier aetio-
logic studies have mostly been conducted. Nevertheless, EPEC and
EAEC should evidently also be included in future analyses of the
aetiology of TD in Latin America.
Study limitations
Multiplex PCRmethods have been criticized as having too high a
sensitivity, as they may identify pathogens in too scanty a number
to cause clinical symptoms. At the same time, it has been recog-
nized that besides the quantity of pathogens, the development of
symptoms also depends on a number of other factors, such as the
infective dose and the host's preexisting immunity. Furthermore,
multiplex PCR assays, by covering a wide selection of pathogens,
reveal themultibacterial nature of TD diseases, thus suggesting that
older studies with narrower coverage of pathogens may have
misinterpreted the role and prevalence of individual findings. The
role of each pathogen needs to be studied further. As a limitation,
our multiplex qPCR did not cover any viral or parasitic pathogens.
Because the stool samples were taken only after travel, the
prevalence of some pathogens may have been underestimated.
EPEC and ETEC were more likely to be found in the specimens of
travellers with ongoing symptoms than those recovered from the
disease, whereas equal rates of Campylobacter and EAEC were
detected in both groups [16]. Indeed, at least ETEC has been sug-
gested to disappear rapidly from stools [25]. Such characteristics of
these pathogens may lead to underestimating the rates of ETEC and
EPEC, thereby overemphasizing the role of Campylobacter and
EAEC. Moreover, despite being more common among travellers
with TD than those asymptomatic in our earlier report [16], the role
of EPEC in TD remains disputable.
T. L€a€averi et al. / Clinical Microbiology and Infection 24 (2018) 908.e9e908.e16 908.e16Practical considerations
Our data indicate that in all the geographical regions we
selected for study, DEC are found in the majority of TD cases, with
EPEC and EAEC as predominating findings. However, it should be
pointed out that the clinical picture of the disease caused by
different pathogens may vary. Campylobacter has been associated
with more severe TD including fever and abdominal pain [28,29]
and ETEC with acute watery diarrhoea [29]. One study suggests
similar clinical pictures for EPEC and ETEC [28]. Although we failed
in our previous report to find differences in the severity of TD
caused by the various TD pathogens, EPEC and EAEC were also
commonly detected in the stool samples of asymptomatic travel-
lers, while ETEC and Campylobacter were almost always associated
with symptomatic disease [16]. Therefore, the prevalence rate of a
pathogen should not be equated to its clinical pertinence.
Conclusions
Whenusingmodernmolecularmethodswith enhanced coverage
of bacterial pathogens, fewer stools remain without any findings (in
our data 26% of thosewith TDduring travel). DECwere revealed to be
the most prevalent pathogens in all regions encompassed by the
study. Indeed,while theproportionsof ETEC andCampylobacterwere
similar or slightly lower than in earlier reports, the main benefit of
modern techniques lies in revealing the concomitant high preva-
lence of EPEC andEAEC. Regional differencesweremostly seen in the
prevalence of ETEC and Campylobacter, yet the multibacterial nature
of the findings attests to the need to redefine the clinical picture and
prevalence of each pathogen.
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